Eurofins Closes on Controlling Stake in Emory Genetics Laboratory | GenomeWeb

NEW YORK (GenomeWeb) – French genomic services firm Eurofins today announced it has successfully acquired a 75 percent stake in the Emory Genetics Laboratory.

The new company will be called EGL Genetic Diagnostics, and will operate as a joint venture of Eurofins and Emory University.

Eurofins said in a statement that the laboratory serves over 400 institutional clients across the US and expects to generate more than $15 million in revenues for the Fiscal Year 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.